24-week Results from the Randomized Phase 2 Dose Expansion Stage of the PRISM Trial Evaluating 4D-150 in High Need nAMD Patients: Injection-free Patient Analyses
/wp-content/uploads/4dmt_logo.svg00Erik Allison/wp-content/uploads/4dmt_logo.svgErik Allison2024-06-06 15:18:302024-06-07 11:48:4824-week Results from the Randomized Phase 2 Dose Expansion Stage of the PRISM Trial Evaluating 4D-150 in High Need nAMD Patients: Injection-free Patient Analyses